# Janpix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/janpix

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.janpix.squarespace.com
- Total disclosed funding: $29M
- Latest round: Series B (Oct 7, 2020)
- Investors on record: 1

## About

Janpix Ltd. is a biotechnology company focused on developing innovative therapies for cancer treatment through advanced drug discovery and development processes.Founded in 2013, Janpix Ltd. is based in Cambridge, US. The company specializes in creating targeted cancer therapies, and it has completed 2 deals, with the most recent deal occurring on October 7, 2020. Janpix raised USD 10.00 mn in Series B funding led by Medicxi Ventures. The CEO is Pierre Cortes, and the company has benefited from the experience of its founders, Anthony Casalena and Roman Fleck.Janpix Ltd. develops cutting-edge therapies aimed at treating various forms of cancer. The company focuses on creating novel drug candidates that leverage advanced scientific techniques to enhance therapeutic efficacy and patient outcomes. Their products target specific cancer pathways, contributing to personalized medicine approaches.Janpix Ltd. operates on a model that includes funding through equity investments, allowing for the support of its research and development activities. The company’s recent funding round of USD 10.00 mn will facilitate the advancement of its cancer therapies and broaden its research capabilities.With the recent funding of USD 10.00 mn from its Series B round completed in October 2020, Janpix Ltd. aims to expedite the development of new cancer therapies. The company plans to expand its research efforts in specific cancer indications and intends to enhance its portfolio with additional novel drug candidates targeted for release within the next two years. Moreover, Janpix is looking to expand its market reach beyond the US into Europe and Asia by 2023.

## Funding rounds

- Series B, Oct 7, 2020, $10M — Medicxi
- Series A, Oct 11, 2017, $19M — Medicxi

## Investors

- Medicxi (https://capitalatlas.ai/funds/medicxi) — Series A, Series B